SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-067323
Filing Date
2024-05-31
Accepted
2024-05-31 18:25:31
Documents
1
Period of Report
2021-11-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2416203-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2416203-1_3seq1.xml 3 3602
  Complete submission text file 0001104659-24-067323.txt   5489
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Reporting) CIK: 0001429260 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41063 | Film No.: 241011380
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9237 E VIA DE VENTURA BLVD., SUITE 105 SCOTTSDALE AZ 85258
Business Address 9237 E VIA DE VENTURA BLVD., SUITE 105 SCOTTSDALE AZ 85258 480-434-6670
Journey Medical Corp (Issuer) CIK: 0001867066 (see all company filings)

IRS No.: 471879539 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)